Related references
Note: Only part of the references are listed.Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection
Carl W. Davis et al.
CELL (2019)
rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment
Thomas P. Monath et al.
VACCINE: X (2019)
Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience
Jae-Hoon Ko et al.
ANTIVIRAL THERAPY (2018)
Transfusion-Transmitted Infections: an Update on Product Screening, Diagnostic Techniques, and the Path Ahead
Christina L. Dean et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
Anti-Ebola Virus Antibody Levels in Convalescent Plasma and Viral Load After Plasma Infusion in Patients With Ebola Virus Disease
Jerry F. Brown et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Characterization of source plasma from self-identified vaccinated or convalescent donors during the 2009 H1N1 pandemic
Alexey Khalenkov et al.
TRANSFUSION (2018)
Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone
Richard S. Tedder et al.
TRANSFUSION (2018)
Plasma treated with amotosalen and ultraviolet A light retains activity for hemostasis after 5 days post-thaw storage at 1 to 6 °C
Anna Erickson et al.
TRANSFUSION (2017)
Comparison of platform technologies for assaying antibody to Ebola virus
Dianna E. Wilkinson et al.
VACCINE (2017)
Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses
Anna Z. Wec et al.
CELL (2017)
The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field
Johan van Griensven et al.
CLINICAL INFECTIOUS DISEASES (2016)
Ebola virus disease: the UK critical care perspective
D. Martin et al.
BRITISH JOURNAL OF ANAESTHESIA (2016)
Ebola Virus Persistence in Semen of Male Survivors
Timothy M. Uyeki et al.
CLINICAL INFECTIOUS DISEASES (2016)
Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea
J. van Griensven et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Efficacy of Convalescent Plasma in Relation to Dose of Ebola Virus Antibodies
Johan van Griensven et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
After Ebola in West Africa - Unpredictable Risks, Preventable Epidemics
Junerlyn Agua-Agum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
S. T. Agnandji et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Clinical Management of Ebola Virus Disease in the United States and Europe
Timothy M. Uyeki et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Overview, Control Strategies, and Lessons Learned in the CDC Response to the 2014-2016 Ebola Epidemic
Beth P. Bell et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2016)
Safety Considerations in the Laboratory Testing of Specimens Suspected or Known to Contain Ebola Virus
Peter C. Iwen et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States
Colleen S. Kraft et al.
CLINICAL INFECTIOUS DISEASES (2015)
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
Angela Huttner et al.
LANCET INFECTIOUS DISEASES (2015)
Persistence of Ebola Virus in Ocular Fluid during Convalescence
Jay B. Varkey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain
Marta Mora-Rillo et al.
LANCET RESPIRATORY MEDICINE (2015)
Is group A thawed plasma suitable as the first option for emergency release transfusion?
Vishesh Chhibber et al.
TRANSFUSION (2014)
Balancing risk and benefit: Maintenance of a thawed Group A plasma inventory for trauma patients requiring massive transfusion
Chelsea R. Mehr et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2013)
Emergency use of prethawed Group A plasma in trauma patients
Martin D. Zielinski et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2013)
Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers
Peter Schlenke et al.
TRANSFUSION (2008)
Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function
Yasmin Singh et al.
TRANSFUSION (2006)
Share Paper
